Article
FDA clinical trial: Myopia study shows benefits of wavefront-guided ablations
Orlando-Six-month results from an FDA clinical trial indicate that customized wavefront-guided LASIK for treatment of myopia with the WavePrint system (VISX) is associated with safe and effective outcomes exceeding FDA targets. The wavefront-guided LASIK is also effective for minimizing increases in higher-order aberrations that can accompany conventional LASIK.
Related Videos
Related Content
Published: December 26th 2024 | Updated: December 26th 2024
Study: Diabetes does not significantly impact outcomes of epiretinal membrane surgery
